Comprehensive Genomic Profiling of Renal Cancer Cases
RNA-seq (gene expression) · human · 121 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 121 samples: 116 × KR_T vs 3 × KUR_TGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Evaluation of the diagnostic concordance of FDA-approved PD-L1 assays in clear cell renal cell carcinomaScientific reports · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE294575_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1250523 and SRA study SRP578538. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 119 samples.
How we read this: 2 replicated groups read from 121 sample titles; they account for 119 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8911598 KR_T141 KR_T
- GSM8911599 KR_T100 KR_T
- GSM8911600 KR_T101 KR_T
- GSM8911601 KR_T102 KR_T
- GSM8911602 KR_T103 KR_T
- GSM8911603 KR_T104 KR_T
- GSM8911604 KR_T105 KR_T
- GSM8911605 KR_T106 KR_T
- GSM8911606 KR_T107 KR_T
- GSM8911607 KR_T108 KR_T
- GSM8911608 KR_T109 KR_T
- GSM8911609 KR_T110 KR_T
- GSM8911610 KR_T111 KR_T
- GSM8911611 KR_T112 KR_T
- GSM8911612 KR_T113 KR_T
- GSM8911613 KR_T114 KR_T
- GSM8911614 KR_T115 KR_T
- GSM8911615 KR_T116 KR_T
- GSM8911616 KR_T117 KR_T
- GSM8911617 KR_T118 KR_T
- GSM8911618 KR_T119 KR_T
- GSM8911619 KR_T120 KR_T
- GSM8911620 KR_T121 KR_T
- GSM8911621 KR_T122 KR_T
- GSM8911622 KR_T123 KR_T
- GSM8911623 KR_T124 KR_T
- GSM8911624 KR_T125 KR_T
- GSM8911625 KR_T126 KR_T
- GSM8911626 KR_T127 KR_T
- GSM8911627 KR_T130 KR_T
- GSM8911628 KR_T131 KR_T
- GSM8911629 KR_T132 KR_T
- GSM8911630 KR_T133 KR_T
- GSM8911631 KR_T134 KR_T
- GSM8911632 KR_T135 KR_T
- GSM8911633 KR_TT136
- GSM8911634 KR_T137 KR_T
- GSM8911635 KR_T138 KR_T
- GSM8911636 KR_T139 KR_T
- GSM8911637 KR_T140 KR_T
+ 81 more — browse all 121 samples with per-sample file links →
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing · shares renal
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares renal
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing · shares renal
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing · shares renal
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing · shares renal
- GSE19982 Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma 30 samples same disease briefing · shares renal
- GSE223688 SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents 6 samples same disease briefing
- GSE214635 The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis 18 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.